Keywords
How to Cite
Abstract
Cutaneous angiosarcoma is a rare tumor with a tendency to be located in the head and neck especially on the scalp and face. It is considered a rapidly growing tumor and often causes distant metastases. The treatment of this tumor is not clearly defined and is based on retrospective studiesand case reports, still seems the best option handling surgery with wide local excision and possibly with negative margins and subsequently adjuvant radiotherapy due to the high rate relapse presented by these tumors. We report the case of a patient of 91 years who received exclusive management with radiotherapy hypofractionated presenting complete response at 3 months after completion and remaining free of disease until the date of this report, 16 months after radiotherapy.
2. Holden CA, Spittle MF. Angiosarcoma of de face and scalp: Prognosis and treatment. Cancer. 1987;59:1046-57.
3. Wilson Jones E. Malignant angioendothelioma of the skin. Br J Dermatol. 1964;76:21-39.
4. Wilson Jones E. Malignant vascular tumours. Clin Exp Dermatol. 1976;1:287-312.
5. Reed RJ, Palomeque FE, Hairston MA III. Lymphangiosarcoma of the scalp. Arch Dermatol. 1966;94:396-402.
6. Cancelliieri A, Eusebio V. Well-differentiated angiosarcoma of skin following radiotherapy. Report of three cases. Pathol Res Pract. 1991;187:301-6.
7. Goette DK, Detlefs RL. Postirradiation angiosarcoma. J Am Academic Dermatol. 1985;12:922-6.
8. Mark RJ, Tran LM, Sercarz J, Fu YS, Calcaterra TC, Juillard GF. Angiosarcoma of the head and neck: The UCLA experience 1955 through 1990. Arch Otolaryngol Head Neck Surg. 1993;119(9):973-8.
9. Holden CA, Spittle MF, Wilson Jones E. Angiosarcoma of the face AND scalp:
Prognosis and treatment. Cancer. 1987;59:1046-57.
10. Naka N, Ohsawa M, Tomita Y, Kanno H, Uchida A, Myoui A, et al. Prognostic factors in angiosarcoma: A multivariate analysis of 55 cases. J Surg Ocol. 1996;61:170-6.
11. Costache M, Ene A, Simionescu O, Sajin M. Histopathological diagnosis of cutaneous vascular sarcomas. Rom J Morphol Embryol. 2010;51(1):105-9.
12. Fury MG, Antonescu CR, Van Zee KJ, et al. A 14-year retrospective review of angiosarcoma: clinical charcteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy. Cancer J. 2005;11:241-7.
13. Mark RJ, Poen JC, Tran LM, Fu YS, Juillard GF. Angiosarcoma: A report of 67 patients and a review of literature. Cancer. 1996;77(11):2400-6.
14. Ogawa K, Takahashi K, Asato Y, Yamamoto Y, Taira K, Matori S, et al. Treatment and prognostic of angiosarcoma of the scalp and face: a retrospective analysis of 48 patients. Br J Radiol. 2012;85(1019):e1127-33.
15. Pawlik TM, Paulino AF, McGinn CJ, Baker LH, Cohen DS, Morris JS, et al. Cutaneous angiosarcoma of scalp: A multidisciplinary approach. Cancer. 2003;98:1716-26.
16. Vatsal B, Patel, Tod W. Successful treatment of an angiosarcoma of the nose with radiation therapy: Case reports in oncology. 2012;5:570-5.
17. DeMartelaere SL, Roberts D, Burgess MA, Morrison WH, Pisters PW, Sturgis EM, et al. Chemotherapy-specific and overall treatment outcomes in patients with cutaneous angiosarcoma of the face. Head Neck. 2008;30(5):639-46.
This journal is registered under a Creative Commons Attribution 4.0 International Public License. Thus, this work may be reproduced, distributed, and publicly shared in digital format, as long as the names of the authors and Pontificia Universidad Javeriana are acknowledged. Others are allowed to quote, adapt, transform, auto-archive, republish, and create based on this material, for any purpose (even commercial ones), provided the authorship is duly acknowledged, a link to the original work is provided, and it is specified if changes have been made. Pontificia Universidad Javeriana does not hold the rights of published works and the authors are solely responsible for the contents of their works; they keep the moral, intellectual, privacy, and publicity rights.
Approving the intervention of the work (review, copy-editing, translation, layout) and the following outreach, are granted through an use license and not through an assignment of rights. This means the journal and Pontificia Universidad Javeriana cannot be held responsible for any ethical malpractice by the authors. As a consequence of the protection granted by the use license, the journal is not required to publish recantations or modify information already published, unless the errata stems from the editorial management process. Publishing contents in this journal does not generate royalties for contributors.